Study Title: A Phase 4 Study to Assess the Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease

Trial Profile

Study Title: A Phase 4 Study to Assess the Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Nov 2017

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Dry eyes
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 16 Nov 2017 Planned initiation date changed from 8 Nov 2017 to 8 Jan 2018.
    • 22 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top